| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Chief Executive Officer
1 company
Ronald T Nixon is Director, 10% Owner at SMTI. Ronald T Nixon's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.2M at current prices.
Net of sales, the SMTI filings show accumulation of 963,856 shares.
Ronald T Nixon has 10 Form 4 filings on record from October 2019 to June 2026, all as Director, 10% Owner at Sanara MedTech (SMTI), 2019–2026.
The 15 reported transactions were 11 stock awards, 2 conversions, 1 other transaction and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $8.0M and no sales.
The only open-market purchase was 963,856 shares of SMTI at an average $8.30 on October 15, 2019, about $8.0M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2019 | SMTI Sanara Medtech Inc. | Director, 10% Owner | Buy | 963,856 | $8.30 | $8,000,004.80 | New |